Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shanghai Kehua Bio-Engineering Co.,Ltd
  6. Summary
    002022   CNE000001KC9

SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD

(002022)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
10/12/2021 10/13/2021 10/14/2021 10/15/2021 10/18/2021 Date
13.17 13.89 13.79 13.42 13.38 Last
4603306 13255350 8604815 7628828 4428791 Volume
-1.57% +5.47% -0.72% -2.68% -0.30% Change
Estimated financial data (e)
Sales 2019 2 414 M 377 M 377 M
Net income 2019 202 M 31,6 M 31,6 M
Net Debt 2019 21,8 M 3,41 M 3,41 M
P/E ratio 2019 29,6x
Yield 2019 0,56%
Sales 2020 4 155 M 648 M 648 M
Net income 2020 675 M 105 M 105 M
Net cash position 2020 1 041 M 162 M 162 M
P/E ratio 2020 11,7x
Yield 2020 1,30%
Capitalization 6 887 M 1 071 M 1 074 M
EV / Sales 2019 2,50x
EV / Sales 2020 1,66x
Nbr of Employees 1 922
Free-Float 75,7%
More Financials
Company
Shanghai Kehua Bio-Engineering Co., Ltd. is a China-based company principally engaged in the research and development, manufacture and sales of diagnostic products. The Company's products include in vitro diagnostic reagents, medical instruments and vacuum blood drawing supplies, among others. The Company operates its businesses in both domestic and overseas markets, with China as its main market. 
More about the company
All news about SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD
08/25Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Half Year Ended..
CI
08/05SANSURE BIOTECH INC. (SHSE : 688289cancelled the acquisition of 18.63% stake in Shanghai K..
CI
07/09Shanghai Kehua Bio-Engineering Co.,Ltd Proposes Final Cash Dividend on A Shares for the..
CI
07/01Shanghai Kehua Bio-Engineering Co.,Ltd Approves Cash Dividend for the Year 2020
CI
06/03Kehua Bio-Engineering to List Newly Unlocked Restricted Shares
MT
05/12Sansure Biotech Inc. agreed to acquire a 18.63% stake in Shanghai Kehua Bio-Engineering..
CI
04/28Shanghai Kehua Bio-Engineering Co.,Ltd Announces Final Profit Distribution Proposal for..
CI
04/27Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter E..
CI
04/06Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended..
CI
2020Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months End..
CI
2020SHANGHAI KEHUA BIO-ENGINEERING CO.,L : 002022) added to S&P Global BMI Index
CI
2020Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Half Year Ended..
CI
2020Shanghai Kehua Bio-Engineering Co.,Ltd Announces 2019 Final Distribution Plan to Be Imp..
CI
2020Shanghai Kehua Bio-Engineering Co.,Ltd. Approves Final Cash Dividend for 2019
CI
2020Shanghai Kehua Bio-Engineering Co.,Ltd Announces Management Changes
CI
More news
News in other languages on SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD

- No features available -

More news
Chart SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD
Duration : Period :
Shanghai Kehua Bio-Engineering Co.,Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
Wei Richard Ding President
Fang Luo Chief Financial & Accounting Officer
Yong Min Hu Chairman
Zhen Li Chairman-Supervisory Board
Qiu Ping Lü Independent Director
Sector and Competitors